Previous close | 55.27 |
Open | 55.33 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 200.00 |
Expiry date | 2025-01-17 |
Day's range | 55.27 - 55.33 |
Contract range | N/A |
Volume | |
Open interest | 37 |
Ferrari, Vertex, ResMed and Hubbel have been highlighted in this Screen of The Week article.
Fears that GLP-1 obesity drugs would reduce demand for ResMed’s various CPAP airflow machines have proven unfounded..
ResMed (RMD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.